文献速递血液净化与透析

IHOPE试验:口服蛋白补充与运动训练对血透患者躯体功能无显著影响

Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.
PubMed 文献 · Kidney Int · 2019-04-02

该随机对照试验纳入138例平均年龄58岁的血液透析患者,随机分为对照组、透析中蛋白补充组、蛋白补充联合运动组,干预12个月。结果显示三组间穿梭步行试验变化无显著差异,部分次要指标有改善趋势但未达统计学意义,提示单纯透析中口服蛋白补充联合有氧运动未能显著改善躯体功能、心血管风险或生活质量。

要点

  • 透析中口服蛋白补充(30g乳清蛋白,每周3次)联合有氧运动12个月未显著改善血透患者躯体功能。
  • 部分躯体功能与肌力次要指标在6或12个月呈改善趋势,但均未达统计学显著性。
  • 对血透患者可能需要更综合的生活方式管理才能带来稳健的健康与生活质量改善。

核心结论

  • 为期12个月的透析中口服蛋白补充联合有氧运动训练未显著改善血液透析患者的躯体功能、心血管疾病风险或生活质量。

研究设计与样本

  • 随机对照试验,共纳入138例平均年龄58岁的血液透析患者,随机分为对照组、透析中蛋白补充组、蛋白补充联合运动组,干预12个月。
  • 蛋白补充组与联合组在透析期间口服30克乳清蛋白补充剂,每周3次;联合组还在透析治疗期间进行30-45分钟功率自行车运动。
  • 主要结局为12个月时穿梭步行试验评估的躯体功能变化;次要结局包括动脉僵硬度、血压、体成分、肌力、营养状态标志物和生活质量,在基线、6个月和12个月进行评估。
  • 共101例患者完成干预。

主要发现

  • 从基线到12个月,三组间穿梭步行试验表现无显著差异。
  • 蛋白补充组和联合组在6或12个月时部分躯体功能和肌力次要指标呈改善趋势,但未达到统计学显著性。

临床怎么用

  • 对于维持性血液透析患者,仅靠透析中口服蛋白补充联合有氧运动训练可能不足以显著改善躯体功能、心血管风险或生活质量,需考虑更综合的生活方式管理。

局限性

  • 138例随机分组中仅101例完成干预,存在一定脱落。
  • 原文未报告具体效应量、置信区间或P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Few long-term studies have assessed whether changes in both diet and exercise can improve the health and quality of life (QOL) of hemodialysis (HD) patients. Here we examined whether 12 months of intradialytic protein supplementation and endurance exercise improves physical function, risk of cardiovascular disease (CVD), and QOL in HD patients in a randomized controlled trial (RCT). A total of 138 HD patients (average age 58 years) were assigned for 12 months to control, intradialytic protein, or protein plus exercise groups. The protein and protein plus exercise groups consumed an oral protein supplement (30 grams of whey) three days/week during dialysis. The protein plus exercise group cycled for 30-45 minutes during dialysis treatment. The primary outcome was change in physical function at 12 months, assessed by a shuttle walk test. Secondary outcomes included arterial stiffness, blood pressure, body composition, muscle strength, markers of nutritional status, and QOL. Assessments were conducted at baseline, 6 and 12 months. In total, 101 patients completed the intervention. There were no significant differences between groups in shuttle walk test performance from baseline to 12 months. There were trends for improvements in some secondary measures of physical function and strength in the protein and protein plus exercise groups at six or 12 months, but these did not reach statistical significance. Thus, our trial did not demonstrate significant improvements in markers of physical function, risk of CVD or QOL after one year of intradialytic oral OPS and aerobic exercise training. More comprehensive lifestyle management may be needed to uncover robust improvements in the health and QOL of HD patients.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Jeong JH, Biruete A, Tomayko EJ, et al. Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients. Kidney Int. 2019. PMID: 31200945. doi:10.1016/j.kint.2019.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。